Trademark: PREAMBLE - PROSPECTIVE RESEARCH ASSESSMENT IN MULTIPLE MYELOMA: AN OBSERVATIONAL EVALUATION
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
PREAMBLE - PROSPECTIVE RESEARCH ASSESSMENT IN MULTIPLE MYELOMA: AN OBSERVATIONAL EVALUATION
Proof of use for PREAMBLE - PROSPECTIVE RESEARCH ASSESSMENT IN MULTIPLE MYELOMA: AN OBSERVATIONAL EVALUATION
We do not have any records of a proof of use for PREAMBLE - PROSPECTIVE RESEARCH ASSESSMENT IN MULTIPLE MYELOMA: AN OBSERVATIONAL EVALUATION at this moment.
Possible trademark infringements of PREAMBLE - PROSPECTIVE RESEARCH ASSESSMENT IN MULTIPLE MYELOMA: AN OBSERVATIONAL EVALUATION
Basic Information
- Serial Number
- 85498760
- Filing Date
- 19 Dec 2011
- Registration Number
- 4832089
- Registration Date
- 13 Oct 2015
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of PREAMBLE - PROSPECTIVE RESEARCH ASSESSMENT IN MULTIPLE MYELOMA: AN OBSERVATIONAL EVALUATION on the blockchain with WikiTrademarks.io.
- First use anywhere
- PREAMBLE - PROSPECTIVE RESEARCH ASSESSMENT IN MULTIPLE MYELOMA: AN OBSERVATIONAL EVALUATION was first used on 31 May 2013 for the primary classification of goods and services, international, 042 (Computer, scientific & legal)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 042
- US Codes
- 100; 101
Ownership history of this trademark/brand
1. Bristol-Myers Squibb Company Princeton NJ
2. Bristol-Myers Squibb Company New York NY
3. Bristol-Myers Squibb Company New York NY
Correspondent
- Marilyn F. Kelly
- Bristol-Myers Squibb Company
- P.O. Box 4000
- Trademark Dept., Mailstop D4243
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io